To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene HMMRTABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
274 supporting clones for gene HMMR back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
NM_001142556.1   .a 1 to 3143 2 to 3144 exact RefSeq,   3144/3144
(100 %)
4 diff
(99.9 %id)
BG724100 testis .a 36 to 627 1 to 592   tiling clone,   592/592
(100 %)
10 diff
(98.4 %id)
DB041494 testis .a 63 to 619 2 to 558   tiling clone, capped   557/557
(100 %)
1 diff
(99.9 %id)
AK313603 testis .a 82 to 2359 1 to 2278 V369A A485V tiling clone,   2278/2278
(100 %)
6 diff
(99.8 %id)
DB073692 testis .a 83 to 630 2 to 549   capped   548/548
(100 %)
2 diff
(99.7 %id)
BI544379 brain, hippocampus .a 84 to 831 1 to 750       750/774
(96 %)
11 diff
(98.6 %id)
TI_44000416   .a 87 to 831 92 to 838   AAA   747/853
(87 %)
13 diff
(98.5 %id)
DB479109 hippocampus .a 89 to 799 1 to 710       710/712
(99 %)
4 diff
(99.5 %id)
DB081950 testis .a 92 to 643 2 to 553   capped   552/553
(99 %)
3 diff
(99.5 %id)
DB041404 testis .a 97 to 643 2 to 549   capped   548/550
(99 %)
5 diff
(99.1 %id)
BC030505 Skin, melanotic melanoma. .a 104 to 1073 12 to 981   available from MGC, AAA   970/970
(100 %)
1 diff
(99.9 %id)
BE891397 melanotic melanoma, skin .a 113 to 833 1 to 719   available from MGC,   719/751
(95 %)
12 diff
(98.5 %id)
BG772653 testis .a 113 to 861 1 to 750       750/753
(99 %)
15 diff
(98.1 %id)
AU099154   .a 118 to 368 50 to 300       251/300
(83 %)
7 diff
(97.7 %id)
DA643720   .a 119 to 547 2 to 430   capped   429/429
(100 %)
1 diff
(99.8 %id)
DA649700   .a 119 to 659 2 to 542   capped   541/541
(100 %)
1 diff
(99.9 %id)
DA649737   .a 119 to 668 2 to 551   capped   550/550
(100 %)
1 diff
(99.9 %id)
DA478264   .a 120 to 684 2 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
AU120436 whole embryo, mainly body .a 120 to 963 2 to 846   capped   845/845
(100 %)
7 diff
(99.2 %id)
CB128359 Liver .a 122 to 553 1 to 432       432/432
(100 %)
4 diff
(99.1 %id)
DA661534   .a 122 to 709 2 to 589   capped   588/588
(100 %)
1 diff
(99.9 %id)
DA665074   .a 122 to 680 2 to 560   capped   559/563
(99 %)
5 diff
(99.2 %id)
DB017684 esophageal, tumor tissue .a 122 to 691 2 to 571   capped   570/570
(100 %)
2 diff
(99.7 %id)
BP873019 embryonal kidney .a 128 to 710 1 to 583       583/583
(100 %)
4 diff
(99.4 %id)
DA604475   .a 129 to 638 2 to 511   capped   510/510
(100 %)
1 diff
(99.9 %id)
DB094664 testis .a 129 to 694 2 to 567   capped   566/566
(100 %)
2 diff
(99.7 %id)
DB153095 thymus .a 129 to 712 2 to 584   capped   583/583
(100 %)
3 diff
(99.5 %id)
BX474336   .a 131 to 734 1 to 604       604/604
(100 %)
3 diff
(99.6 %id)
BF209869 bone marrow, from chronic myelogenous leukemia .a 131 to 764 1 to 639       639/732
(87 %)
22 diff
(97.0 %id)
DB108007 thymus .a 131 to 709 2 to 580   capped   579/579
(100 %)
3 diff
(99.5 %id)
BE564329 bladder, carcinoma, cell line .a 137 to 731 1 to 588       588/897
(65 %)
10 diff
(98.9 %id)
DB048964 testis .a 137 to 705 2 to 573   capped   572/572
(100 %)
4 diff
(99.4 %id)
U29343 normal breast .a 140 to 2876 19 to 2756 E278D K299T K323E Q331R R333H tiling clone,   2738/2756
(99 %)
16 diff
(99.5 %id)
BY797836 eye .a 143 to 762 1 to 620       620/620
(100 %)
1 diff
(99.9 %id)
BU198953   .a 145 to 796 1 to 650       650/651
(99 %)
17 diff
(97.4 %id)
BC107869 placenta .a 145 to 1623 1 to 1478   AAA   1478/1480
(99 %)
7 diff
(99.6 %id)
BC108904 PCR rescued clones .a 148 to 2774 1 to 2627 R93C V369A A485V     2627/2627
(100 %)
4 diff
(99.9 %id)
BG573544 placenta .a 148 to 1028 1 to 874       818/878
(93 %)
17 diff
(98.1 %id)
DB163298 thymus .a 150 to 703 2 to 555   capped   554/554
(100 %)
1 diff
(99.9 %id)
DB164041 thymus .a 150 to 731 2 to 583   capped   582/584
(99 %)
3 diff
(99.5 %id)
DA992499 synovial membrane tissue from rheumatioidarthritis .a 154 to 689 2 to 537   capped   536/536
(100 %)
1 diff
(99.9 %id)
H87394 placenta .a 170 to 525 1 to 367       367/394
(93 %)
18 diff
(95.5 %id)
CN304734 embryonic stem cells, cell lines H1, H7, andH9 .a 180 to 622 1 to 443       443/443
(100 %)
2 diff
(99.6 %id)
CN304740 embryonic stem cells, cell lines H1, H7, andH9 .a 202 to 705 1 to 504       504/504
(100 %)
1 diff
(99.9 %id)
EH343433   .a 215 to 270 1 to 56       56/57
(98 %)
2 diff
(96.5 %id)
BM788751 stomach .a 330 to 846 1 to 517       517/517
(100 %)
0 diff
(100 %id)
DB128897 thymus .a 425 to 981 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
AU146502 whole embryo, mainly body .a 2594 to 3134 542 to 1   tiling clone,   542/545
(99 %)
6 diff
(98.9 %id)
NM_012484.2   .b 1 to 3140 2 to 3141 exact RefSeq,   3141/3141
(100 %)
4 diff
(99.9 %id)
AF032862   .b 146 to 3131 1 to 2986 R103S tiling clone, AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 2986/2986
(100 %)
2 diff
(100.0 %id)
BI561131 testis .c 1 to 713 8 to 717   tiling clone,   710/718
(98 %)
7 diff
(99.1 %id)
TI_44348809   .c 1 to 713 94 to 803       710/804
(88 %)
12 diff
(98.6 %id)
DB461303 testis .c 76 to 555 1 to 480       480/480
(100 %)
2 diff
(99.6 %id)
NM_012485.2   .c 146 to 3241 1 to 3096 exact RefSeq,   3096/3096
(100 %)
4 diff
(99.9 %id)
DB091289 testis .c 147 to 716 2 to 571   tiling clone, capped   570/570
(100 %)
2 diff
(99.7 %id)
BC057235 testis .c 176 to 2135 1 to 1960   available from MGC, AAA   1960/1960
(100 %)
4 diff
(99.8 %id)
BU569112 testis .c 177 to 830 1 to 660   available from MGC,   660/806
(81 %)
14 diff
(98.3 %id)
DB091739 testis .c 228 to 782 2 to 556   capped   555/555
(100 %)
1 diff
(99.9 %id)
DB082422 testis .c 237 to 808 2 to 574   capped   573/573
(100 %)
2 diff
(99.7 %id)
DB077166 testis .c 265 to 802 2 to 539   capped   538/538
(100 %)
2 diff
(99.7 %id)
BP871241 embryonal kidney .c 267 to 597 1 to 331       331/331
(100 %)
1 diff
(99.7 %id)
BC006984 Bladder, carcinoma .c 267 to 1841 1 to 1575   available from MGC, AAA   1575/1575
(100 %)
5 diff
(99.7 %id)
DA767394 tongue .c 268 to 829 2 to 563   capped   562/564
(99 %)
3 diff
(99.5 %id)
DA820059   .c 268 to 849 2 to 583   capped   582/582
(100 %)
2 diff
(99.7 %id)
DB109140 thymus .c 268 to 834 2 to 568   capped   567/567
(100 %)
2 diff
(99.7 %id)
DB134945 thymus .c 268 to 814 2 to 548   capped   547/547
(100 %)
2 diff
(99.7 %id)
DB153819 thymus .c 268 to 838 2 to 572   capped   571/571
(100 %)
1 diff
(99.9 %id)
BF183958 bone marrow, from chronic myelogenous leukemia .c 269 to 889 1 to 627   available from MGC,   627/798
(78 %)
12 diff
(98.5 %id)
BC070281 Bone marrow, chronic myelogenous leukemia .c 270 to 1952 1 to 1683   available from MGC, AAA   1683/1685
(99 %)
6 diff
(99.7 %id)
DB134932 thymus .c 275 to 802 2 to 529   capped   528/528
(100 %)
2 diff
(99.7 %id)
BC017793 Testis, embryonal carcinoma .c 277 to 1289 1 to 1013   available from MGC, AAA   1013/1015
(99 %)
2 diff
(99.9 %id)
BG530996 embryonal carcinoma, testis .c 277 to 934 1 to 671   available from MGC,   671/814
(82 %)
32 diff
(96.1 %id)
DA442942 tongue, tumor tissue .c 279 to 857 2 to 580   capped   579/579
(100 %)
2 diff
(99.7 %id)
DA652194   .c 279 to 755 2 to 480   capped   479/483
(99 %)
4 diff
(99.2 %id)
DA666043   .c 279 to 835 2 to 558   capped   557/557
(100 %)
2 diff
(99.7 %id)
DB147736 thymus .c 279 to 855 2 to 578   capped   577/577
(100 %)
1 diff
(99.9 %id)
DB139614 thymus .c 281 to 802 2 to 523   capped   522/522
(100 %)
2 diff
(99.7 %id)
CN304735 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 285 to 951 1 to 667       667/667
(100 %)
4 diff
(99.5 %id)
DR002760 fetal brain .c 285 to 1013 1 to 729       729/729
(100 %)
4 diff
(99.5 %id)
BG942774 blood .c 287 to 806 1 to 520       520/520
(100 %)
3 diff
(99.5 %id)
BF029349 bladder, carcinoma, cell line .c 287 to 806 1 to 516   available from MGC,   516/518
(99 %)
12 diff
(97.7 %id)
DR157400 human embryonic stem cells differentiated toan early endodermal cell type .c 290 to 1139 1 to 850       850/850
(100 %)
2 diff
(99.8 %id)
CD655612 Embryonic Stem cells .c 292 to 1126 12 to 842       831/860
(96 %)
23 diff
(97.4 %id)
BC108905 PCR rescued clones .c 294 to 2872 1 to 2580 L580I Q652T S653K E654* tiling clone,   2580/2580
(100 %)
3 diff
(99.9 %id)
DB143361 thymus .c 296 to 820 2 to 526   capped   525/525
(100 %)
1 diff
(99.9 %id)
CN304731 embryonic stem cells, DMSO-treated H9 cellline .c 299 to 620 1 to 323       323/323
(100 %)
3 diff
(99.1 %id)
AK290577   .c 305 to 2825 1 to 2521 Q532R tiling clone,   2521/2521
(100 %)
2 diff
(100.0 %id)
CN304742 embryonic stem cells, cell lines H1, H7, andH9 .c 306 to 902 1 to 597       597/597
(100 %)
3 diff
(99.5 %id)
DA547429   .c 306 to 879 2 to 575   capped   574/574
(100 %)
2 diff
(99.7 %id)
CB044512 colon, juvenile granulosa tumor .c 306 to 899 43 to 636       594/636
(93 %)
7 diff
(98.9 %id)
BE080585 breast .c 316 to 677 14 to 376       363/376
(96 %)
10 diff
(97.4 %id)
CN304732 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 331 to 990 1 to 660       660/660
(100 %)
2 diff
(99.7 %id)
BM749418 stomach .c 367 to 805 5 to 443       439/443
(99 %)
6 diff
(98.7 %id)
CN304739 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 372 to 656 1 to 285       285/285
(100 %)
3 diff
(99.0 %id)
NM_001142557.1   .d 1 to 2916 2 to 2917 exact RefSeq,   2917/2917
(100 %)
3 diff
(99.9 %id)
AK303616 thymus .d 122 to 2206 1 to 2085 V282A A398V tiling clone,   2085/2085
(100 %)
5 diff
(99.8 %id)
DC410670 thymus .d 122 to 700 1 to 580       580/580
(100 %)
2 diff
(99.7 %id)
BF244555 brain, glioblastoma .d 263 to 839 1 to 573       573/906
(63 %)
6 diff
(99.4 %id)
AA553484 Schwannoma tumor .d 330 to 847 518 to 1       518/518
(100 %)
0 diff
(100 %id)
AI570551 anaplastic oligodendroglioma, brain .d 333 to 846 514 to 1       514/514
(100 %)
1 diff
(99.9 %id)
AA747811 germinal center B cell .d 348 to 851 508 to 5       504/508
(99 %)
4 diff
(99.3 %id)
CX866128 embryonic stem .d 365 to 1125 1 to 761       761/761
(100 %)
2 diff
(99.8 %id)
DA478521   .d 396 to 964 2 to 571   capped   570/571
(99 %)
2 diff
(99.7 %id)
AU131763   .d 404 to 1220 2 to 818   capped   817/818
(99 %)
9 diff
(98.9 %id)
AA760626 germinal center B cell .d 414 to 851 443 to 5       439/499
(87 %)
18 diff
(96.4 %id)
EC448500 Prostate .d 419 to 528 1 to 108       108/108
(100 %)
7 diff
(93.6 %id)
BX409882 neuroblastoma .d 606 to 1325 1 to 719       719/794
(90 %)
18 diff
(97.8 %id)
CN304736 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 630 to 1199 1 to 570       570/570
(100 %)
4 diff
(99.3 %id)
BM800632 leiomyosarcoma, uterus .d 657 to 1567 1 to 933       934/1096
(85 %)
38 diff
(96.6 %id)
FN048270 breast carcinoma .d 744 to 810 1 to 65       65/66
(98 %)
2 diff
(97.0 %id)
CN304743 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 785 to 1353 1 to 569       569/569
(100 %)
0 diff
(100 %id)
BQ222022 melanotic melanoma, skin .d 797 to 1617 1 to 829       829/900
(92 %)
12 diff
(98.7 %id)
AU132065   .d 823 to 1646 2 to 829   capped   828/874
(94 %)
10 diff
(98.9 %id)
TI_154034149   .d 859 to 1629 871 to 105   AAA   767/889
(86 %)
15 diff
(98.4 %id)
BM826372 Ascites, stomach .d 883 to 1409 1 to 527       527/527
(100 %)
1 diff
(99.9 %id)
CA443399 Fibrosarcoma .d 919 to 1629 725 to 16   AAA   710/711
(99 %)
2 diff
(99.8 %id)
CD251935 testis .d 925 to 1778 27 to 883   tiling clone,   856/896
(95 %)
14 diff
(98.5 %id)
TI_149305850   .d 928 to 1646 796 to 85   AAA   714/885
(80 %)
15 diff
(98.4 %id)
AA172109.
matches multiple genes
  .d 933 to 1318 1 to 386     also hits gene kenumo 386/386
(100 %)
2 diff
(99.5 %id)
BM978555 lung, Primary Lung Epithelial Cells .d 985 to 1646 680 to 20   AAA   661/661
(100 %)
1 diff
(99.9 %id)
AA452176   .d 990 to 1339 1 to 350       350/351
(99 %)
1 diff
(99.8 %id)
BF184967 bone marrow, from chronic myelogenous leukemia .d 1022 to 1728 1 to 702       702/832
(84 %)
19 diff
(97.8 %id)
BF692487 melanotic melanoma, high MDR, skin .d 1039 to 1613 1 to 576       576/864
(66 %)
14 diff
(98.4 %id)
BI850350 melanotic melanoma, high MDR, skin .d 1040 to 1673 1 to 625       630/628
(100 %)
12 diff
(98.1 %id)
T77539 liver and spleen .d 1077 to 1421 1 to 349     Submitted on the opposite strand 349/351
(99 %)
10 diff
(97.2 %id)
BI088333 cervix .d 1083 to 1917 1 to 841       842/899
(93 %)
24 diff
(97.4 %id)
BC033568 Skin, normal .d 1087 to 2903 1 to 1817   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 1817/1817
(100 %)
2 diff
(99.9 %id)
T80617 liver and spleen .d 1088 to 1339 1 to 252     Submitted on the opposite strand 252/253
(99 %)
3 diff
(98.9 %id)
R10285 liver and spleen .d 1088 to 1490 1 to 414     Submitted on the opposite strand 414/433
(95 %)
16 diff
(96.4 %id)
BQ215292 embryonal carcinoma, cell line, testis .d 1135 to 1917 1 to 789   AAA   789/932
(84 %)
22 diff
(97.7 %id)
CN304738 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 1162 to 1938 1 to 776       776/776
(100 %)
2 diff
(99.8 %id)
CN304737 embryonic stem cells, DMSO-treated H9 cellline .d 1194 to 1760 1 to 567       567/567
(100 %)
1 diff
(99.9 %id)
BY997277   .d 1239 to 1800 1 to 562       562/562
(100 %)
0 diff
(100 %id)
R10284 liver and spleen .d 1402 to 1719 325 to 1     Submitted on the opposite strand 325/325
(100 %)
12 diff
(96.4 %id)
CB118516 Liver .d 1410 to 1974 1 to 565       565/565
(100 %)
0 diff
(100 %id)
AA164923   .d 1411 to 1588 1 to 178       178/179
(99 %)
1 diff
(99.5 %id)
T77575 liver and spleen .d 1437 to 1764 332 to 1     Submitted on the opposite strand 332/333
(99 %)
10 diff
(97.0 %id)
T80726 liver and spleen .d 1441 to 1717 286 to 1     Submitted on the opposite strand 286/326
(87 %)
14 diff
(95.8 %id)
BF209839 bone marrow, from chronic myelogenous leukemia .d 1442 to 2083 1 to 640       640/897
(71 %)
34 diff
(96.3 %id)
BF743908 breast .d 1522 to 1725 205 to 1     Submitted on the opposite strand 205/229
(89 %)
10 diff
(95.7 %id)
TI_157610877   .d 1538 to 1912 64 to 438     Submitted on the opposite strand 375/790
(47 %)
7 diff
(99.2 %id)
AW373169 breast .d 1554 to 1678 1 to 124       124/124
(100 %)
7 diff
(94.4 %id)
BQ366876 placenta_normal .d 1592 to 1944 23 to 378       356/378
(94 %)
11 diff
(97.1 %id)
BF244634 brain, glioblastoma .d 1597 to 2318 1 to 720       720/925
(77 %)
46 diff
(95.1 %id)
AA234261 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 1601 to 1801 1 to 201       201/202
(99 %)
2 diff
(99.1 %id)
BE538026 cervix .d 1603 to 2087 1 to 483       483/583
(82 %)
7 diff
(98.8 %id)
CN304741 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 1607 to 2349 9 to 749       741/749
(98 %)
8 diff
(99.0 %id)
BF900350 marrow .d 1608 to 1997 1 to 393       393/394
(99 %)
29 diff
(92.7 %id)
CB132559 Liver .d 1611 to 2171 1 to 561       561/561
(100 %)
0 diff
(100 %id)
BF850862 lung_normal .d 1614 to 1988 1 to 375       375/375
(100 %)
7 diff
(98.2 %id)
BQ226364 melanotic melanoma, skin .d 1623 to 2087 1 to 465       465/1069
(43 %)
10 diff
(99.1 %id)
BM849217 myeloma .d 1661 to 2211 1 to 551       551/551
(100 %)
0 diff
(100 %id)
BG496817 lung, mucoepidermoid carcinoma .d 1672 to 2442 1 to 778       778/966
(80 %)
26 diff
(97.4 %id)
AI890711 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .d 1767 to 2276 510 to 1       510/510
(100 %)
3 diff
(99.5 %id)
BM744927 stomach .d 1770 to 2337 1 to 567       567/567
(100 %)
2 diff
(99.7 %id)
BM747624 stomach .d 1770 to 2313 1 to 544       544/544
(100 %)
3 diff
(99.5 %id)
BM772368 stomach .d 1770 to 2415 1 to 647       647/647
(100 %)
1 diff
(99.9 %id)
CR601287 Neuroblastoma Cot 10-normalized .d 1773 to 2840 1 to 1068       1068/1068
(100 %)
0 diff
(100 %id)
AL519957 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .d 1773 to 2784 1 to 1005   fully sequenced,   1005/1005
(100 %)
21 diff
(98.0 %id)
BI091750 cervix .d 1797 to 2559 1 to 761       761/761
(100 %)
6 diff
(99.3 %id)
BE567953 bladder, carcinoma, cell line .d 1841 to 2543 1 to 694       694/903
(76 %)
48 diff
(94.7 %id)
AA410932 ovarian tumor, ovary .d 1849 to 2246 1 to 399       399/399
(100 %)
5 diff
(98.8 %id)
BG219770   .d 1907 to 2173 40 to 305       266/305
(87 %)
16 diff
(94.8 %id)
BG198320   .d 1909 to 2153 50 to 300       251/300
(83 %)
6 diff
(98.0 %id)
BG191223   .d 1910 to 2651 48 to 796       749/825
(90 %)
87 diff
(89.5 %id)
BG214018   .d 1911 to 2686 1 to 774       774/778
(99 %)
9 diff
(98.9 %id)
BG217749   .d 1911 to 2689 1 to 777       777/777
(100 %)
22 diff
(97.2 %id)
BG183878   .d 1912 to 2583 64 to 734       671/792
(84 %)
46 diff
(94.2 %id)
BG204019   .d 1912 to 2574 51 to 718       668/784
(85 %)
73 diff
(90.7 %id)
BG193318   .d 1913 to 2581 1 to 678       678/721
(94 %)
30 diff
(95.9 %id)
BG201946   .d 1913 to 2672 1 to 769       769/773
(99 %)
29 diff
(96.3 %id)
BG210312   .d 1913 to 2688 1 to 778       778/780
(99 %)
15 diff
(98.1 %id)
BG220261   .d 1913 to 2547 1 to 635       635/761
(83 %)
35 diff
(95.5 %id)
BG221223   .d 1913 to 2705 1 to 793       793/801
(99 %)
17 diff
(97.9 %id)
BG205051   .d 1914 to 2678 1 to 763       763/763
(100 %)
10 diff
(98.7 %id)
BG209304   .d 1914 to 2147 49 to 281       233/284
(82 %)
9 diff
(96.9 %id)
BG214017   .d 1914 to 2701 1 to 787       787/788
(99 %)
7 diff
(99.2 %id)
BG211339   .d 1915 to 2249 1 to 336       336/336
(100 %)
6 diff
(98.3 %id)
BG191224   .d 1919 to 2542 52 to 672       621/835
(74 %)
37 diff
(95.6 %id)
BG220725   .d 1922 to 2705 1 to 777       777/780
(99 %)
34 diff
(95.7 %id)
BM725946 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .d 1925 to 2420 1 to 496     Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 496/496
(100 %)
0 diff
(100 %id)
BG198860   .d 1942 to 2709 16 to 798       783/798
(98 %)
59 diff
(92.7 %id)
CN304733 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 1983 to 2554 1 to 572       572/572
(100 %)
0 diff
(100 %id)
AA461217   .d 2009 to 2485 1 to 475       475/475
(100 %)
2 diff
(99.6 %id)
AL519956 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .d 2298 to 2810 513 to 1   fully sequenced,   645/645
(100 %)
19 diff
(97.1 %id)
AU153677   .d 2332 to 2907 572 to 1       572/574
(99 %)
11 diff
(98.1 %id)
AA460915   .d 2487 to 2900 416 to 3       414/416
(99 %)
0 diff
(100 %id)
BM680960 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .d 2539 to 2903 383 to 19   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 365/365
(100 %)
0 diff
(100 %id)
DB368808   .d 2577 to 2904 331 to 4       328/334
(98 %)
0 diff
(100 %id)
AA164270   .d 2705 to 2907 203 to 1   tiling clone,   203/203
(100 %)
1 diff
(99.6 %id)
AA262978 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 2723 to 2903 181 to 1       181/181
(100 %)
0 diff
(100 %id)
CX866045 embryonic stem .d 2784 to 2913 154 to 25   tiling clone,   130/154
(84 %)
0 diff
(100 %id)
BX503450 Liver .e 1 to 528 1 to 528 E49* tiling clone,   528/528
(100 %)
6 diff
(98.9 %id)
BQ057571 lymph, lymphoma, cell line .e 466 to 1163 1 to 704   tiling clone,   704/1271
(55 %)
13 diff
(99.0 %id)
BG334937 melanotic melanoma, skin .e 879 to 1217 1 to 337   tiling clone,   337/975
(34 %)
8 diff
(99.2 %id)
BM014269 breast, mammary adenocarcinoma, cell line .e 1015 to 1619 1 to 604   tiling clone, AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 604/604
(100 %)
2 diff
(99.7 %id)
TI_59392262   .e 1015 to 1619 89 to 692   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 604/604
(100 %)
2 diff
(99.7 %id)
AW976921   .e 1059 to 1612 562 to 1     Submitted on the opposite strand 562/565
(99 %)
28 diff
(95.1 %id)
DW410889 Liver .e 1075 to 1388 17 to 331       315/331
(95 %)
6 diff
(98.2 %id)
AA804515 germinal center B cell .e 1168 to 1613 473 to 28   tiling clone, AAA Possibly primed on the genome, locally A rich (18/20 A in genome downstream of last aligned base) 446/446
(100 %)
0 diff
(100 %id)
AA761497 germinal center B cell .e 1264 to 1586 322 to 1       322/322
(100 %)
2 diff
(99.4 %id)
DW419072 Liver .f-u 1 to 389 21 to 409   tiling clone,   392/409
(95 %)
6 diff
(98.6 %id)
DW464780 Liver .f-u 1 to 342 21 to 362       345/362
(95 %)
6 diff
(98.4 %id)
BC002966 Lung, small cell carcinoma .f-u 254 to 2188 1 to 1936 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (25/25 A in genome downstream of last aligned base) 1936/1936
(100 %)
1 diff
(100.0 %id)
BE264131 lung, small cell carcinoma .f-u 273 to 720 1 to 448       448/451
(99 %)
1 diff
(99.8 %id)
DW427470 Liver .f-u 702 to 964 17 to 279       263/279
(94 %)
6 diff
(97.9 %id)
DW455915 Liver .f-u 1618 to 1760 17 to 158       142/172
(82 %)
6 diff
(96.6 %id)
CR748597 germinal center B cell .g 1 to 663 1 to 663 exact tiling clone,   663/671
(98 %)
2 diff
(99.8 %id)
AI243683 pooled .g 585 to 987 403 to 1   tiling clone,   403/403
(100 %)
4 diff
(99.1 %id)
AA731267 germinal center B cell .g 663 to 960 298 to 1   tiling clone,   298/298
(100 %)
7 diff
(97.7 %id)
DB066815 testis .h-u 1 to 270 2 to 271 exact tiling clone, to resequence, capped   270/273
(98 %)
1 diff
(99.7 %id)
BE086537 breast .h-u 1262 to 1476 12 to 226       215/226
(95 %)
6 diff
(97.4 %id)
BE086539 breast .h-u 1262 to 1510 28 to 276   tiling clone,   249/282
(88 %)
1 diff
(99.7 %id)
AW370490 breast .h-u 1383 to 1700 1 to 318       318/318
(100 %)
23 diff
(92.8 %id)
BM764295 lymph node, stomach .h-u 1390 to 2012 1 to 623   tiling clone,   623/623
(100 %)
0 diff
(100 %id)
AW370410 breast .h-u 1473 to 1700 1 to 230       230/230
(100 %)
6 diff
(97.4 %id)
BP429800   .h-u 1475 to 1831 1 to 357       357/357
(100 %)
4 diff
(98.9 %id)
AW748434 breast .h-u 1479 to 1700 1 to 223       223/223
(100 %)
7 diff
(96.9 %id)
BP429834   .h-u 1490 to 1856 1 to 367       367/367
(100 %)
2 diff
(99.5 %id)
BQ000586 Fibrosarcoma .h-u 1494 to 2206 732 to 19   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 714/728
(98 %)
1 diff
(99.9 %id)
BQ027031 Chondrosarcoma, Left Pubic Bone .h-u 1496 to 2206 730 to 19   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 712/729
(97 %)
1 diff
(99.9 %id)
DB547783 hippocampus .h-u 1498 to 2206 1 to 703     Submitted on the opposite strand 703/703
(100 %)
9 diff
(98.8 %id)
AW748417 breast .h-u 1530 to 1700 1 to 171       171/171
(100 %)
5 diff
(97.1 %id)
BE568520 bladder, carcinoma, cell line .h-u 1535 to 2207 1 to 674       674/763
(88 %)
28 diff
(96.4 %id)
BE892436 melanotic melanoma, skin .h-u 1536 to 2175 1 to 640       640/640
(100 %)
0 diff
(100 %id)
DB508697 testis .h-u 1539 to 2206 1 to 666     Submitted on the opposite strand 666/666
(100 %)
4 diff
(99.4 %id)
BQ010466 Chondrosarcoma, Left Pubic Bone .h-u 1550 to 2206 675 to 19   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 657/657
(100 %)
1 diff
(99.9 %id)
DB526716 testis .h-u 1558 to 2212 1 to 653     Submitted on the opposite strand 653/655
(99 %)
5 diff
(99.3 %id)
AW440513 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .h-u 1559 to 2208 649 to 1       649/649
(100 %)
15 diff
(97.7 %id)
CR592683 Neuroblastoma Cot 25-normalized .h-u 1561 to 2212 1 to 652   tiling clone,   652/652
(100 %)
0 diff
(100 %id)
BX393921 Neuroblastoma Cot 25-normalized .h-u 1561 to 2212 1 to 652       652/652
(100 %)
4 diff
(99.4 %id)
BG027860 Bone, osteosarcoma, cell line .h-u 1592 to 2180 28 to 620       593/903
(65 %)
31 diff
(96.6 %id)
AI401492 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .h-u 1632 to 2207 575 to 1       575/578
(99 %)
10 diff
(98.3 %id)
BE086277 breast .h-u 1638 to 1859 7 to 228       222/234
(94 %)
7 diff
(97.1 %id)
BE086336 breast .h-u 1638 to 1859 7 to 228       222/234
(94 %)
7 diff
(97.1 %id)
DB339782 testis .h-u 1669 to 2206 538 to 1   to resequence,   538/538
(100 %)
0 diff
(100 %id)
BE327167 carcinoid, lung .h-u 1676 to 2206 531 to 1       531/531
(100 %)
0 diff
(100 %id)
AI215478 pooled .h-u 1694 to 2208 515 to 2       514/517
(99 %)
0 diff
(100 %id)
AA593010 colon, colon tumor RER+ .h-u 1732 to 2201 470 to 1       470/470
(100 %)
0 diff
(100 %id)
BE042983 carcinoid, lung .h-u 1735 to 2206 472 to 1       472/472
(100 %)
0 diff
(100 %id)
AI024828   .h-u 1746 to 2212 467 to 1       467/467
(100 %)
2 diff
(99.6 %id)
AW592647 pooled .h-u 1746 to 2204 461 to 3       459/461
(99 %)
0 diff
(100 %id)
BU588815 mixed (pool of 40 RNAs) .h-u 1756 to 2206 1 to 451   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 451/451
(100 %)
2 diff
(99.6 %id)
AW070617 pooled .h-u 1757 to 2204 449 to 2       448/449
(99 %)
0 diff
(100 %id)
D12029 Liver .h-u 1772 to 2201 1 to 431       431/431
(100 %)
13 diff
(97.0 %id)
AA632211 breast .h-u 1778 to 2205 429 to 1       429/429
(100 %)
1 diff
(99.8 %id)
AI094426 pooled .h-u 1779 to 2198 419 to 1       419/419
(100 %)
1 diff
(99.8 %id)
AI209041 placenta .h-u 1782 to 2206 435 to 11   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 425/425
(100 %)
0 diff
(100 %id)
AA909904 pooled .h-u 1798 to 2206 422 to 14   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 409/409
(100 %)
0 diff
(100 %id)
AI140612   .h-u 1805 to 2206 435 to 34   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 402/402
(100 %)
0 diff
(100 %id)
AW104442 pooled .h-u 1809 to 2212 411 to 8       404/411
(98 %)
0 diff
(100 %id)
BF109034 pooled .h-u 1809 to 2199 394 to 4       391/394
(99 %)
0 diff
(100 %id)
AA972656 carcinoid, lung .h-u 1812 to 2208 398 to 2       397/398
(99 %)
0 diff
(100 %id)
AA781831   .h-u 1813 to 2199 389 to 3       387/389
(99 %)
0 diff
(100 %id)
AA912764 pooled .h-u 1828 to 2206 392 to 14   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 379/379
(100 %)
0 diff
(100 %id)
AI215541 pooled .h-u 1830 to 2208 380 to 2       379/380
(99 %)
0 diff
(100 %id)
AA687269 germinal center B cell .h-u 1839 to 2206 406 to 39   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 368/368
(100 %)
0 diff
(100 %id)
AW629232 pooled .h-u 1843 to 2212 373 to 4       370/373
(99 %)
0 diff
(100 %id)
AI799134 pooled .h-u 1844 to 2208 366 to 2       365/366
(99 %)
0 diff
(100 %id)
AA743743 germinal center B cell .h-u 1848 to 2212 368 to 4       365/368
(99 %)
0 diff
(100 %id)
BG942106 blood .h-u 1876 to 2212 360 to 25       336/360
(93 %)
0 diff
(100 %id)
AA831946 germinal center B cell .h-u 1884 to 2206 357 to 35   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 323/323
(100 %)
0 diff
(100 %id)
AA612782 colon, colon tumor RER+ .h-u 1898 to 2207 311 to 1       311/313
(99 %)
4 diff
(98.8 %id)
AI088336 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .h-u 1915 to 2206 292 to 1       292/292
(100 %)
0 diff
(100 %id)
AW082168 pooled .h-u 1917 to 2194 278 to 1       278/278
(100 %)
2 diff
(99.3 %id)
BU536054 mixed (pool of 40 RNAs) .h-u 2008 to 2205 1 to 198   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 198/198
(100 %)
2 diff
(99.0 %id)
BF477938 carcinoid, lung .h-u 2016 to 2208 194 to 2       193/194
(99 %)
0 diff
(100 %id)
AW057729 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .h-u 2031 to 2206 176 to 1       176/176
(100 %)
0 diff
(100 %id)
BG219858   .h-u 2052 to 2212 200 to 40     Submitted on the opposite strand 161/200
(80 %)
0 diff
(100 %id)
BX369737 Neuroblastoma Cot 25-normalized .h-u 2057 to 2212 6 to 164       159/169
(94 %)
5 diff
(97.1 %id)
EC484783 Prostate .h-u 2110 to 2202 94 to 2       93/94
(98 %)
0 diff
(100 %id)
GD157663   .h-u 2141 to 2210 1 to 70   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 70/70
(100 %)
4 diff
(94.3 %id)
DB027223 testis .i 1 to 610 2 to 611 exact tiling clone, capped   610/610
(100 %)
2 diff
(99.7 %id)
BM787841 stomach Gene HMMR, variant not shown         Suspected internal deletion, this clone was ignored    
AY623426   Gene HMMR, variant not shown         This clone was ignored    
DB443724 testis Gene HMMR, variant not shown         This clone was ignored    
AK302975 testis Gene HMMR, variant not shown         Suspected internal deletion, this clone was ignored    
DR003426 fetal brain Gene HMMR, variant not shown         This clone was ignored    
BG771851 testis Gene HMMR, variant not shown         This clone was ignored    
CD244356 testis Gene HMMR, variant not shown         This clone was ignored    
DB085082 testis Gene HMMR, variant not shown       capped This clone was ignored    
DB092842 testis Gene HMMR, variant not shown       capped This clone was ignored    
DC403945 testis Gene HMMR, variant not shown         Suspected internal deletion, this clone was ignored    
BF245963 brain, glioblastoma Gene HMMR, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f-u, .g, .h-u, .i Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI